Generic Name and Formulations:
Bupropion HBr 174mg (equiv. to bupropion HCl 150mg), 348mg (equiv. to bupropion HCl 300mg), 522mg (equiv. to bupropion HCl 500mg); ext-rel tabs.
Indications for APLENZIN:
Treatment of major depressive disorder (MDD). Prevention of seasonal affective disorder (SAD).
Swallow whole. Take in the AM. MDD: Initially 174mg once daily; after 4 days, may increase to target dose of 348mg once daily. SAD: Individualize. Start therapy in autumn, prior to onset of symptoms; continue through the winter season; taper dose and discontinue early spring. Initially 174mg once daily; after 7 days, may increase to target dose of 348mg once daily. Severe hepatic impairment: max 174mg every other day. Renal or mild-moderate hepatic dysfunction: reduce dose and/or frequency. All: increase dose gradually to reduce seizure risk: max 522mg once daily.
Seizure disorder or conditions that increase seizure risk (eg, arteriovenous malformation, severe head injury, CNS tumor/infection, severe stroke, anorexia nervosa or bulimia, or abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs. Within 14 days of MAOIs (eg, phenelzine).
Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor all patients for clinical worsening or unusual behavioral changes. Monitor for neuropsychiatric adverse events (eg, behavioral changes, agitation, depression, suicidal ideation); evaluate and consider treatment continuation under closer monitoring, or discontinuation if occur. Pre-existing psychiatric disorders. Bipolar disorder. Mania/hypomania. Psychosis. Risk of seizures; discontinue if seizure occurs: do not restart. Angle-closure glaucoma. Unstable heart disease. CHF. Recent MI. Monitor BP before initiating and periodically during treatment. Hepatic or renal impairment (monitor closely). Maintain at lowest effective dose. Write ℞ for smallest practical amount. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.
See Contraindications. Avoid alcohol. May be potentiated by CYP2B6 inhibitors (eg, ticlopidine, clopidogrel), paroxetine, sertraline, fluvoxamine, nelfinavir. May be antagonized by CYP2B6 inducers (eg, ritonavir, lopinavir, efavirenz), others (eg, carbamazepine, phenobarbital, phenytoin). Caution with drugs that lower seizure threshold (eg, other bupropion products, antipsychotics, antidepressants, theophylline, systemic corticosteroids, anorectic drugs, benzodiazepines, sedative/hypnotics, opiates, oral hypoglycemics, insulin). Caution with levodopa, amantadine, and with drugs metabolized by CYP2D6 including tricyclic antidepressants, SSRIs, antipsychotics, β-blockers, Class 1C antiarrhythmics; consider dose reduction. May cause false (+) results in urine immunoassay tests for amphetamine.
Dry mouth, nausea, insomnia, dizziness, pharyngitis, abdominal pain, agitation, anxiety, tremor, palpitation, sweating, tinnitus, myalgia, anorexia, urinary frequency, rash (may be serious, eg, Stevens-Johnson syndrome); hypertension, neuropsychiatric events.
Psychiatry Advisor Articles
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia
- Retirement Saving Behavior Associated With Psychological Distress
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder
- Enhanced Vaccination Effectiveness in Older Adults Linked to Positive Mood
- Subjective Cognitive Decline Linked to Alzheimer Biomarker
- Unnecessary Costs Associated With Low-Cost, Low-Value Health Services
- Is Hypertension Linked to an Increased Risk of Dementia?